@article{3fe0a3b7992f42a69cc6c27eff30a0d1,
title = "Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated doses of statins",
abstract = "Alirocumab is a fully human monoclonal antibody to proprotein convertase subtilisin kexin type 9 (PCSK9) under investigation for treatment of hypercholesterolemia and reduction of cardiovascular events.",
author = "Colhoun, {Helen M.} and Robinson, {Jennifer G.} and Michel Farnier and Bertrand Cariou and Dirk Blom and Kereiakes, {Dean J.} and Christelle Lorenzato and Robert Pordy and Umesh Chaudhari",
note = "10.1186/1471-2261-14-121 Article 1471-2261",
year = "2014",
doi = "10.1186/1471-2261-14-121",
language = "English",
volume = "14",
pages = "121",
journal = "Bmc cardiovascular disorders",
issn = "1471-2261",
publisher = "BioMed Central",
number = "1",
}